Search company, investor...

Phase Forward

Founded Year



Acq - P2P | Acquired

Total Raised




About Phase Forward

Phase Forward (NASDAQ: PFWD) is a developer and marketer of an Internet-based system for collecting clinical trial data

Headquarters Location

77 Fourth Avenue

Waltham, Massachusetts, 02451,

United States


Missing: Phase Forward's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Phase Forward's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Phase Forward Patents

Phase Forward has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Incineration, Centrifuges, Rotation, Waste treatment technology, Force


Application Date


Grant Date



Related Topics

Incineration, Centrifuges, Rotation, Waste treatment technology, Force



Latest Phase Forward News

Phase Forward raises $34.6 million in IPO - Boston Business Journal

Jun 19, 2013

Phase Forward raises $34.6 million in IPO Jul 15, 2004, 10:05am EDT Updated Jul 15, 2004, 10:05am EDT //= $authorImg ?> Save Article Data management software maker Phase Forward Inc. raised $34.6 million in its initial public stock offering -- roughly half of what it had hoped to generate when it initially filed its intention to go public. The company sold 5.25 million shares at $7.50 per share, a price slightly under the $8 to $10 per-share range it had planned for. The number of shares was also fewer than what observers had speculated would be offered. The life sciences software company filed an IPO in mid-March estimated at the time to be worth as much as $86.3 million, with estimates in June coming in closer to the range of $64 million to $80 million. The company's software helps pharmaceutical, biotechnology and medical device companies manage their clinical trials better. Phase Forward's shares are quoted on the Nasdaq National Market under the symbol "PFWD" beginning Thursday. Thomas Weisel Partners LLC, Piper Jaffray & Co. and Raymond James & Associates Inc. are the underwriters. They have a 30-day option to purchase up to 787,500 additional shares of common stock. Phase Forward lost $14.3 million in 2003 on sales of $62 million, according to public filings. Want Boston news in your inbox? Sign up for our free email newsletters. Suggested Reading

Phase Forward Frequently Asked Questions (FAQ)

  • When was Phase Forward founded?

    Phase Forward was founded in 1997.

  • Where is Phase Forward's headquarters?

    Phase Forward's headquarters is located at 77 Fourth Avenue, Waltham.

  • What is Phase Forward's latest funding round?

    Phase Forward's latest funding round is Acq - P2P.

  • How much did Phase Forward raise?

    Phase Forward raised a total of $99.1M.

  • Who are the investors of Phase Forward?

    Investors of Phase Forward include Oracle, Sprout Group, SV Health Investors, aPriori Capital Partners, Thomas Weisel Partners and 8 more.

  • Who are Phase Forward's competitors?

    Competitors of Phase Forward include Implantable Provider Group, Caladrius Biosciences, ArisGlobal, National Surgical Healthcare, ThreeWire and 12 more.

Compare Phase Forward to Competitors

ArisGlobal Logo

Aris Global is a provider of Pharmacovigilance, Drug Safety Software & Monitoring, Clinical Trials Management, Medical Communications and Regulatory software solutions to the pharmaceutical and life sciences industries.

Norton Audits Logo
Norton Audits

Norton Audits aims to provide clinical trial monitoring, auditing, and training.

Chiral Quest

Chiral Quest develops routes for intermediates and APIs and manages tech transfer to full-scale manufacturing. Chiral Quest aims to help its customers improve their operating efficiencies by: (1) shortening the time-line for production of complex APIs; (2) developing a scalable process that will provide increasing quantities as clinical trials advance; (3) managing an efficient and cost-effective supply chain for manufacture; (4) providing robust QC methods and a strong CMC package.

NCI Cancer Hospital

NCI Cancer Hospital is a private oncology centre in Malaysia that combines treatment and clinical research. NCI aims to provide a range of services from diagnosis, laboratory analysis, surgery, chemotherapy and radiotherapy. It operates to GCP and has conducted clinical trials for a number of pharmaceutical companies including Roche, BMS and AstraZeneca.

E&C Medical Intelligence

E&C Medical Intelligence is involved in automated clinical management support and documentation.

athenahealth Logo

athenahealth offers billing, practice management, and EHR services. athenahealth's offering is a web-based software, rules database offered as a subscription to physicians that combines in-office practice management functionality with a billing service. It is based in Watertown, Massachusetts.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.